Tobias Kammann

Tobias Kammann

Affiliated to Research
Visiting address: Alfred Nobels allé 8, plan 7, 14152 Huddinge
Postal address: H7 Medicin, Huddinge, H7 CIM Sandberg, 171 77 Stockholm

About me

  • I enjoy exploring the human immune system. In my research, I study human tissue-resident T cells and want to understand how T cells mediate homeostasis in their environment, eliminate threats, improve tolerance, and repair damage.

    Currently, I characterize mucosal effector-memory CD4 T cells resident in the human gastrointestinal barrier.

    In my PhD at the Center for Infectious Medicine, I uncovered the diversity of mucosal-associated invariant T (MAIT) cells across the human body to understand their role in tissue homeostasis and immune defence. During the COVID-19 pandemic, I joined the Karolinska's efforts to better understand how the human immune system responds to the disease.

    Before I joined Karolinska Institutet, I trained as a paramedic, then studied biochemistry at the Friedrich Schiller University in Jena, Germany, with a focus on liver dysfunction and sepsis research.

Articles

All other publications

Grants

  • Charting the human tissue terrain of regulatory T cell immunity and memory against respiratory viruses
    Swedish Society for Medical Research
    7 July 2025 - 7 July 2028
    Regulatory T (Treg) cells are specialized immune cells that are essential for balancing the activity of the immune system. In human tissues, Treg cells not only suppress exacerbated immune activity and thereby prevent self-harm but also aid in repair, a role that appears especially crucial in the respiratory system where diseases like COVID-19 can cause severe organ damage. However, our knowledge on how Treg cells contribute to immune memory, tissue repair and protection from viral disease is mostly limited to animal models. In collaboration with Columbia University, New York, USA, and Karolinska Institutet, Stockholm, Sweden, this project seeks to explore how human tissue-resident Treg cells contribute to protection against respiratory viruses. Our research will use mucosal and lymphoid tissues from human organ donors to examine memory Treg cells that respond specifically to viral antigens. We will profile antiviral Treg cell characteristics on an epigenetic, transcriptomic, and functional level and further apply cutting-edge technology to map and track individual Treg populations within human lymphoid tissues to deepen our understanding on how Treg cells establish antiviral immune memory and support adaptive immune responses. Together, this research aims to chart the terrain of antiviral Treg cells in human tissues and offers insights that could lead to targeted therapies enhancing resilience against respiratory tract infections.
  • Swedish Research Council
    1 July 2025 - 30 June 2028
    Regulatory T (Treg) cells are specialized immune cells that are essential for balancing the activity of the immune system. In human tissues, Treg cells not only suppress exacerbated immune activity but also aid in repair, a role that appears especially crucial in the respiratory system where diseases like COVID-19 can cause severe organ damage. However, our knowledge on how Treg cells contribute to immune memory, tissue repair and protection from viral disease is mostly limited to animal models.In collaboration with Columbia University, New York, USA, and Karolinska Institutet, Stockholm, Sweden, this project seeks to explore how human tissue-resident Treg cells contribute to protection against respiratory viruses. Our research will use mucosal and lymphoid tissues from human organ donors to examine memory Treg cells that respond specifically to viral antigens. We will profile antiviral Treg cell characteristics on an epigenetic, transcriptomic, and functional level and further apply cutting-edge technology to map and track individual Treg populations within human lymphoid tissues to deepen our understanding on how Treg cells establish antiviral memory and support adaptive immune responses.Together, this research aims to chart the terrain of antiviral Treg cells in human tissues and offers insights that could lead to novel Treg cell-targeting therapies enhancing resilience against respiratory tract infections.

Employments

  • Affiliated to Research, Department of Medicine, Huddinge, Karolinska Institutet, 2025-2027
  • Postdoctoral Researcher, Department of Medicine Solna, Karolinska Institutet, 2025-2025
  • Postdoctoral Researcher, Department of Medicine Huddinge, Karolinska Institutet, 2024-2025
  • Doctoral Researcher (PhD candidate), Human tissue-resident T cell immunology, Department of Medicine Huddinge, Karolinska Institutet, 2020-2024

News from KI

Events from KI